An interim safety analysis of the first randomized controlled trial of its kind involving over 80,000 Swedish women published in The Lancet Oncology journal, finds artificial intelligence (AI)-supported mammography analysis is as good as two breast radiologists working together to detect breast cancer, without increasing false positives and almost halving the screen-reading workload.
from Medical Xpress - latest medical and health news stories https://ift.tt/lLMFqJ8
